Molbio Diagnostics Limited
NSE: MOLBIO | Information Technology
Market Fundamentals
Stock Intelligence & News
Molbio Diagnostics Ltd (544866)
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for India Business Excellence Fund III,
Read Full Analysis →Molbio Diagnostics shares jump 5% as HDFC MF buys 1.99% stake via bulk deal | Newly listed stock up 71% from IPO price
Molbio Diagnostics shares rose over 5% on October 1, after HDFC Mutual Fund acquired a 1.99% stake. The stock gained approximately 71% since its IPO, and Jefferies assigned a ‘Buy’ rating, setting a target price of ₹1,600, indicating over 98% upside potential.
Read Full Analysis →Motilal Oswal Alternates sells over 2% stake in Molbio Diagnostics for ₹306 cr
Business Excellence Trust III, a fund of Motilal Oswal Alternates, offloaded 23.28 lakh shares of Goa-based Molbio Diagnostics at an average price of ₹1,315.01 apiece
Read Full Analysis →AI-Powered Alerts for Your Portfolio
Alerfo's AI classifies every news event by type, severity, and market impact — then instantly notifies you via Email & WhatsApp only for the stocks you track.
Molbio Diagnostics shares rally 9% as Jefferies initiates 'high conviction top pick' call for recently listed stock. Why is it bullish?
Molbio Diagnostics shares jumped after Jefferies initiated coverage with a Buy rating and named it a high-conviction top pick. The brokerage set a Rs 1,600 target price, implying 27% upside from Tuesday’s close and nearly 98% above its Rs 807 IPO price. The stock had listed at a 21% premium at Rs 980.
Read Full Analysis →Molbio Diagnostics Stock Soars 9% As It Becomes Jefferies Top Med Tech Pick At Initiation
Shares soared to a high of Rs 1,369.20, but pared most of their gains to trade 4% higher at Rs 1,305 apiece on the NSE.
Read Full Analysis →Molbio Diagnostics Limited
Molbio Diagnostics Limited has informed the Exchange regarding Outcome of Board Meeting held on September 25, 2026 for re-appointment of M/s K. S. Kamalakara & Co, Cost Accountants as the Cost Auditor of the Company for FY 2026-27. |SUBJECT: Outcome of Board Meeting
Read Full Analysis →Molbio Diagnostics Ltd (544866)
The Exchange has received the revised disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for India Business Excellence Fund III
Read Full Analysis →Molbio Diagnostics Ltd (544866)
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for India Business Excellence Fund III
Read Full Analysis →Molbio Diagnostics Ltd (544866)
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for India Business Excellence Fund III
Read Full Analysis →Molbio Diagnostics Ltd (544866)
Intimation of Analysts/Investors Meeting under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, scheduled to be held on Tuesday, September 22, 2026 at 11.00 A.M.(IST) onwards.
Read Full Analysis →Get instant alerts when MOLBIO breaks news
Join investors who track Molbio Diagnostics Limited on Alerfo — free plan available.
Set Free Alert →Frequently Asked Questions
What is the current trend for MOLBIO?
MOLBIO is currently showing a volatility profile consistent with its sector peers, with sentiment being actively monitored by Alerfo news scanners.
How can I set alerts for Molbio Diagnostics Limited?
You can set real-time price and news alerts by registering on the Alerfo platform and adding MOLBIO to your custom watchlist.